buyModerate
Kevin Tang bought $1.8M of OMIC
owner at Singular Genomics Systems, Inc.. 122,416 shares at an average of $14.75, traded Sep 16, 2024, filed Sep 18, 2024.
Conviction score
48Value
$1.8M
122,416 shares
Holdings after
372,000
+49% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +25Trade size$1.8M at market
- +6Relative to holdingsHoldings up 49%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- +10Track recordMedian 6-month excess return +10% over 4 past buys
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-023623, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 16, 2024 | POpen-market purchase Common Stockindirect: By LP | +50,416 | $12.74 | $642k | 300,000 | Sep 18, 2024 |
| Sep 17, 2024 | POpen-market purchase Common Stockindirect: By LP | +40,000 | $15.33 | $613k | 340,000 | Sep 18, 2024 |
| Sep 18, 2024 | POpen-market purchase Common Stockindirect: By LP | +32,000 | $17.21 | $551k | 372,000 | Sep 18, 2024 |
Related signals
Other insiders at Singular Genomics Systems, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | OMICsell Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $3,629 180 shares | -22% | |
| 20Weak | OMICsell Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $16k 695 shares | -31% | |
| 15Weak | OMICsell Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $2,167 175 shares | -22% | |
| 32Weak | Singular Genomics Systems, Inc. | Eli N. Glezer Chief Scientific Officer | $86k 200,000 shares | +5% | |
| 40Moderate | Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $50k 118,468 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.